logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

GENOR-B(06998) spent HK$2.604 million on February 4th to repurchase 997,500 shares.

date
20:47 04/02/2026
avatar
GMT Eight
Jiawei Biotechnology (06998) announced that on February 4, 2026, they spent 2.604 million Hong Kong dollars to repurchase 997,500 shares.
GENOR-B (06998) issued an announcement on February 4, 2026, to repurchase 997,500 shares at a cost of 2.604 million Hong Kong dollars.
Related Articles
HK Stock
SUNAC SERVICES (01516) subscribes to 200 million yuan of fixed income financial products.
HK Stock
MEGA GENOMICS (06667) announces its mid-year performance for 2025, with a net profit of 27.3 million yuan.
HK Stock
XJ INTL HLDGS (01765) recommends increasing the authorized share capital.
SUNAC SERVICES (01516) subscribes to 200 million yuan of fixed income financial products.
HK Stock
MEGA GENOMICS (06667) announces its mid-year performance for 2025, with a net profit of 27.3 million yuan.
HK Stock
XJ INTL HLDGS (01765) recommends increasing the authorized share capital.
HK Stock
RECOMMEND
Multiple A‑Share Companies Update Hong Kong IPO Progress Since Start Of Year
Multiple A‑Share Companies Update Hong Kong IPO Progress Since Start Of Year
icon
30/01/2026
Mainland Pharmaceutical Companies Rush To Hong Kong, Over 10 Firms Queue For IPO
Mainland Pharmaceutical Companies Rush To Hong Kong, Over 10 Firms Queue For IPO
icon
30/01/2026
2026 Hong Kong Market Faces Unlocking Peak: HKD 1.6 Trillion In Restricted Shares To Be Released, How Will The Market Respond?
2026 Hong Kong Market Faces Unlocking Peak: HKD 1.6 Trillion In Restricted Shares To Be Released, How Will The Market Respond?
icon
30/01/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.